^ Janeway, Charles. Immunobiology: the immune system in health and disease 6th. New York: Garland Science. 2005. ISBN 0-8153-4101-6 .
Krista Conger. Grant to fund research into preventing bioterrorism (頁面存檔備份 ,存於互聯網檔案館 ), Stanford Report, November 12, 2003.
Stenger S, Hanson DA, Teitelbaum R, et al. An antimicrobial activity of cytolytic T cells mediated by granulysin . Science. October 1998, 282 (5386): 121–5. PMID 9756476 . doi:10.1126/science.282.5386.121 .
Peña SV, Hanson DA, Carr BA, Goralski TJ, Krensky AM. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins . J. Immunol. March 1997, 158 (6): 2680–8. PMID 9058801 .
Krensky AM, Clayberger C. Granulysin: a novel host defense molecule . Am. J. Transplant. August 2005, 5 (8): 1789–92. PMID 15996224 . doi:10.1111/j.1600-6143.2005.00970.x .
da Silva AP, Unks D, Lyu SC, et al. In vitro and in vivo antimicrobial activity of granulysin-derived peptides against Vibrio cholerae . J. Antimicrob. Chemother. May 2008, 61 (5): 1103–9. PMC 2664651 . PMID 18310138 . doi:10.1093/jac/dkn058 .
Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, Chin SW, Chiou CC, Chu SC, Ho HC, Yang CH, Lu CF, Wu JY, Liao YD, Chen YT. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med. Dec 2008, 14 (12): 1343–50. doi:10.1038/nm.1884 .
^ 1.0 1.1 1.2 GRCh38: Ensembl release 89: ENSG00000115523 - Ensembl , May 2017
^ Human PubMed Reference: . National Center for Biotechnology Information, U.S. National Library of Medicine.